Cart
sales@molnova.com
Histamine Phosphate
CAS No. 51-74-1
Histamine Phosphate( Histamine diphosphate )
Catalog No. M18704 CAS No. 51-74-1
Histamine acts directly on the blood vessels to dilate arteries and capillaries mediated by both H 1- and H 2-receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 27 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHistamine Phosphate
-
NoteResearch use only, not for human use.
-
Brief DescriptionHistamine acts directly on the blood vessels to dilate arteries and capillaries mediated by both H 1- and H 2-receptors.
-
DescriptionHistamine acts directly on the blood vessels to dilate arteries and capillaries mediated by both H 1- and H 2-receptors.
-
In Vitro——
-
In Vivo——
-
SynonymsHistamine diphosphate
-
PathwayOthers
-
TargetOther Targets
-
RecptorHistamine H1 receptor , Histamine H2 receptor
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number51-74-1
-
Formula Weight307.14
-
Molecular FormulaC5H9N·2H3O4P
-
Purity>98% (HPLC)
-
SolubilityH2O : ≥ 42 mg/mL; 136.75 mM
-
SMILESOP(O)(O)=O.OP(O)(O)=O.NCCC1=CNC=N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Plevin R, et al. J Neurochem, 1988, 51(2), 634-641.
molnova catalog
related products
-
Hederagenin 3-O-(2-O...
Hederagenin 3-O-(2-O-acetyl-α-L-arabinopyranoside) significantly increased alkaline phosphatase (ALP) activity and the level of protein expression of bone sialoprotein (BSP) and osteocalcin (OC) .
-
Divalproex Sodium
Divalproex Sodium binds to and inhibits gamma-aminobutyric acid (GABA) transaminase and its anticonvulsant activity may be exerted by increasing brain concentration of GABA and by inhibiting enzymes that catabolize GABA or block the reuptake of GABA into glia and nerve endings.
-
3',4'-Anhydrovinblas...
3', 4'-Anhydrovinblastine is an antineoplastic agent.
